Skip to main content

Companies Participating In 39th J.P. Morgan Healthcare Conference 2021

The Annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry. The 39th J.P. Morgan Healthcare Conference is will be held from January 11-13, 2021











Participating Companies
10x Genomics, Inc.
Abbott
Abiomed
Acadia Pharmaceuticals Inc
Acceleron
Acceleron
Acceleron Pharma Inc.
Acutus Medical, Inc.
Adaptive Biotechnologies
Aeglea BioTherapeutics, Inc.
Agile Therapeutics, Inc.
Akebia Therapeutics
Akero Therapeutics
AlloVir
Alnylam
Alpine Immune Sciences, Inc.
Amarin Corporation plc
Amedisys, Inc.
AngioDynamics
Aptinyx Inc
Arena Pharmaceuticals, Inc.
argenx SE
Ascendis Pharma
Atea Pharmaceuticals, Inc.
Autolus Therapeutics plc
Avantor and Financial News
Avidity Biosciences, Inc.
AVITA Medical

B
Baxter International Inc.
BD (Becton, Dickinson and Company)
Berkeley Lights, Inc
BeyondSpring, Inc.
Biomarin Pharmaceuticals
Bio-Techne Corporation
BioXcel Therapeutics
Boston Scientific Corporation
Bristol Myers Squibb

C
Chinook Therapeutics, Inc.
Cigna
CVS Health Corporation
Cyclerion Therapeutics, Inc.

D
Dicerna

E
Eagle Pharmaceuticals
Eargo
Editas Medicine, Inc.
Elanco to Participate
Eli Lilly and Company
Emergent BioSolutions
Esperion Therapeutics, Inc.
EXACT SCIENCES CORP
Exelixis

F
Freeline Therapeutics

G
GenMark Diagnostics, Inc.
Gilead Sciences, Inc.
Glaukos
GoodRx

H
Halozyme Therapeutics, Inc.
Hansa Biopharma AB
Health Catalyst, Inc.
Henry Schein
Horizon Therapeutics
Humana Inc.
Humanigen, Inc.

I
Illumina, Inc. (NASDAQ:ILMN)
ImmunoGen
Inogen, Inc.
Inspire Medical Systems, Inc.
Insulet Corporation
Integra LifeSciences Holdings Corporation
Invitae Corporation
Iovance Biotherapeutics, Inc.
iRhythm
IVERIC bio, Inc

J
Jazz Pharmaceuticals plc

K
Kala Pharmaceuticals
Karyopharm Therapeutics Inc.
Kiniksa Pharmaceuticals, Ltd.

L
Leap Therapeutics, Inc.
Legend Biotech Corporation
Luminex Corporation

M
McDermott Will & Emery
Medtronic plc
Merck
Merck
MiMedx Group, Inc
Mirati Therapeutics, Inc.
Mirum Pharmaceuticals
MISONIX, Inc.
Moderna
Molina Healthcare
Morphic Therapeutic
MTBC
Myriad Genetics, Inc.

N
NanoString
Neurocrine Biosciences, Inc.
Nevro Corp.
NextGen Healthcare, Inc.
Novanta Inc.
Novocure
NuVasive, Inc.

O
Olema Oncology
Omnicell, Inc.
Option Care Health, Inc.
ORIC Pharmaceuticals
Oyster Point Pharma, Inc.

P
Passage Bio
Patterson Companies
Penumbra, Inc.
PerkinElmer, Inc.
PPD
Precision Biosciences
Protagonist Therapeutics, Inc.
PTC Therapeutics, Inc.
PureTech Health plc

R
R1 RCM Inc.
Regeneron Pharmaceuticals, Inc.
Renalytix AI plc.
Repare Therapeutics
Repligen Corporation
Rite Aid
Rubius Therapeutics

S
Sage Therapeutics
Salarius Pharmaceuticals, Inc.
Scholar Rock
Seagen Inc.
Seer, Inc.
SI-BONE, Inc.
Silk Road Medical
Sotera Health Services, LLC
Stoke Therapeutics
Syneos Health, Inc.

T
Tabula Rasa HealthCare, Inc.
TCR2 Therapeutics
Teleflex Incorporated
The Providence Service Corporation
TherapeuticsMD
Tivity Health
TransMedics Group, Inc.
Twist Bioscience

U
United Therapeutics Corporation
Universal Health Services, Inc.

V
Vericel Corporation
ViewRay, Inc.
Virios Therapeutics

W
Walgreens Boots Alliance
Waters Corporation

Z
Zai Lab Limited
Zimmer Biomet Holdings, Inc.
ZIOPHARM Oncology Inc
Zoetis Inc.

Comments

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

MCQs and Answers on cultivation (culture/incubation), Isolation and Identification of microorganisms: Medical Microbiology

40 plus questions - Multiple Choice Questions on Classification, Culture, and Identification of the microorganisms 1. Which of the following microorganism has the cocci cell shapes and sizes arranged usually in tetrad structures? a)  Streptococcus pneumoniae b)  Staphylococcus aureus c)  Chlamydia trachomatis d)  Neisseria meningitidis 2. What are the different growth morphology and cell structures used for the classification of fungi? Select all the correct answers: a) Yeast b) Mold c) Mycelia d) Protozoa 3. Which of the following media is formulated with additional nutrients to support the growth of fastidious or nutritionally demanding bacteria that may not grow well on basic media? a) Differential media b) Enriched media c) Nutrient agar (media) d) Selective media 4. Which of the following metabolic characteristic is a distinguishing characteristic and identification of colonies of  E. coli ? a) Hydrogen sulfide formation b) Indole Formation c) Lactose fe...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...